TVM Capital Life Science
21
12M
17
0.51
7
0.19
4
- Stages of investment
- Areas of investment
Summary
In 2012 was created TVM Capital Life Science, which is appeared as VC. The venture was found in Europe in Germany. The main department of described VC is located in the Munich.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2015. This TVM Capital Life Science works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. Considering the real fund results, this VC is 42 percentage points more often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the TVM Capital Life Science, startups are often financed by Triathlon Medical Venture Partners, Pearl Street Venture Funds, Pappas Ventures. The meaningful sponsors for the fund in investment in the same round are Triathlon Medical Venture Partners, StandUp Ventures, Signet Healthcare Partners.
We also calculated 3 valuable employees in our database.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Emovi, Acer Therapeutics, CoLucid Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Clinical Trials, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups.
Investments analytics
Analytics
- Total investments
- 21
- Lead investments
- 7
- Exits
- 4
- Rounds per year
- 0.51
- Follow on index
- 0.19
- Investments by industry
- Health Care (12)
- Biotechnology (11)
- Medical (9)
- Medical Device (7)
- Pharmaceutical (6) Show 17 more
- Investments by region
-
- United States (7)
- Germany (6)
- Canada (5)
- United Kingdom (2)
- Switzerland (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 72M
- Group Appearance index
- 0.62
- Avg. company exit year
- 8
- Avg. multiplicator
- 1.82
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Smart Reporting | 22 Apr 2024 | Health Care, Health Diagnostics, Medical | Late Stage Venture | 27M | Munich, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.